Research ArticleClinical Studies

The Combination of Epirubicin plus Docetaxel as Neoadjuvant Chemotherapy in Locally-advanced Breast Cancer

AKIRA HIRANO, TADAO SHIMIZU, HIROSHI IMAMURA, OSAMU WATANABE, JUN KINOSHITA, TOSHIHIRO OKABE, KIYOMI KIMURA, MARI KAMIMURA, KAORU DOMOTO, MOTOHIKO AIBA and KENJI OGAWA
Anticancer Research January 2006, 26 (1B) 581-584;

Article Information

vol. 26 no. 1B 581-584
PMID 
16739324
Published By 
International Institute of Anticancer Research
Print ISSN 
0250-7005
Online ISSN 
1791-7530
History 
  • Received October 3, 2005
  • Accepted November 25, 2005
  • Published online January 1, 2006.
Copyright & Usage 
Copyright© 2006 International Institute of Anticancer Research (Dr. John G. Delinassios), All rights reserved

Author Information

  1. AKIRA HIRANO1,*,
  2. TADAO SHIMIZU1,*,
  3. HIROSHI IMAMURA1,
  4. OSAMU WATANABE1,
  5. JUN KINOSHITA1,
  6. TOSHIHIRO OKABE1,
  7. KIYOMI KIMURA1,
  8. MARI KAMIMURA1,
  9. KAORU DOMOTO1,
  10. MOTOHIKO AIBA2 and
  11. KENJI OGAWA1
  1. 1Department of Surgery, Tokyo Women's Medical University Daini Hospital, Tokyo 116-8567, Japan
  2. 2Department of Surgical Pathology, Tokyo Women's Medical University Daini Hospital, Tokyo 116-8567, Japan
  1. Correspondence to: Kenji Ogawa, MD, 2-1-10 Nishiogu, Arakawaku, Tokyo 116-8567, Japan. Tel: +81-3-3810-1111, Fax: +81-3-3894-5493, e-mail: ogawasu{at}dnh.twmu.ac.jp

Statistics from Altmetric.com

Cited By...

Back to top

In this issue

Download PDF
Article Alerts
Email Article
Citation Tools
Reprints and Permissions
The Combination of Epirubicin plus Docetaxel as Neoadjuvant Chemotherapy in Locally-advanced Breast Cancer
AKIRA HIRANO, TADAO SHIMIZU, HIROSHI IMAMURA, OSAMU WATANABE, JUN KINOSHITA, TOSHIHIRO OKABE, KIYOMI KIMURA, MARI KAMIMURA, KAORU DOMOTO, MOTOHIKO AIBA, KENJI OGAWA
Anticancer Research Jan 2006, 26 (1B) 581-584;
Twitter logo Facebook logo Mendeley logo

Jump to section